跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
meganucleases
首页
药物
meganucleases
meganucleases
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Rationally designed meganucleases with altered sequence specificity and DNA-binding affinity
EP 2628794 B1
申请人: PREC BIOSCIENCES
优先权: 2005
EP
US
48 件公开
CUSTOM-MADE MEGANUCLEASE AND USE THEREOF
EP 3202899 B1
申请人: CELLECTIS
优先权: 2003
EP
US
WO
26 件公开
Rationally-designed single-chain meganucleases with non-palindromic recognition sequences
EP 2660317 A1
申请人: PREC BIOSCIENCES INC
优先权: 2007
EP
US
WO
20 件公开
ENGINEERED MEGANUCLEASES SPECIFIC FOR RECOGNITION SEQUENCES IN THE HEPATITIS B VIRUS GENOME
EP 3526323 B1
申请人: PREC BIOSCIENCES INC
优先权: 2016
CN
EP
US
WO
13 件公开
ENGINEERED MEGANUCLEASES HAVING SPECIFICITY FOR RECOGNITION SEQUENCES IN THE DYSTROPHIN GENE
EP 4244342 B1
申请人: PREC BIOSCIENCES INC
优先权: 2020
CN
EP
US
WO
12 件公开
ENGINEERED MEGANUCLEASES SPECIFIC FOR RECOGNITION SEQUENCES IN THE PCSK9 GENE
EP 4269596 A2
申请人: PREC BIOSCIENCES INC
优先权: 2017
CN
EP
US
WO
9 件公开
TREATMENT OF RETINITIS PIGMENTOSA USING ENGINEERED MEGANUCLEASES
EP 3347463 C0
申请人: PREC BIOSCIENCES INC
优先权: 2015
EP
US
WO
9 件公开
ENGINEERED MEGANUCLEASES WITH RECOGNITION SEQUENCES FOUND IN THE HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE
EP 3359660 B1
申请人: PREC BIOSCIENCES INC
优先权: 2015
EP
US
WO
8 件公开
OPTIMIZED ENGINEERED MEGANUCLEASES HAVING SPECIFICITY FOR A RECOGNITION SEQUENCE IN THE HEPATITIS B VIRUS GENOME
EP 3775187 A1
申请人: PREC BIOSCIENCES INC
优先权: 2018
EP
US
WO
8 件公开
EP 4069729 B1
申请人: PREC BIOSCIENCES INC
优先权: 2019
EP
US
WO
6 件公开
ENGINEERED MEGANUCLEASES HAVING SPECIFICITY FOR A RECOGNITION SEQUENCE IN THE HEPATITIS B VIRUS GENOME
EP 4805491 A1
申请人: PREC BIOSCIENCES INC
优先权: 2023
CN
EP
US
WO
7 件公开
第 1 / 4 页
上一页
下一页
药物
反馈